What is the global market size of the Platelet Rich Plasma Market?

Global Platelet Rich Plasma Market size was valued at USD 546.6 million in 2021 and is poised to grow from USD 629.19 million in 2022 to USD 2232.54 million by 2030, growing at a CAGR of 11.15% in the forecast period (2023-2030).

Platelet Rich Plasma Companies

Q: Which region accounted for the largest share in the Global Platelet Rich Plasma Market?

North America dominated the Global Platelet Rich Plasma Market share in 2021. This may be ascribed to the existence of several production facilities eager to create innovative PRP-based treatment methods, the high procurement at end-users including hospitals and clinics, and the presence of significant market participants. The market presence was reinforced by the assistance and approvals given by regulatory bodies. Such actions are predicted to increase market availability of platelet-rich plasma and speed up growth. During the projected period, it is predicted that the U.S. would provide promising growth opportunities. In the nation, PRP-based therapies are extensively used, with an increase in orthopaedic and aesthetic operations. The prominence of major players in the U.S together with the developed healthcare system in the nation, will also continue to influence the demand prognosis for platelet-rich plasma over the evaluation period. Due to these developments, the industry is anticipated to have a 3/10th market share.

Platelet Rich Plasma Market Competitive Landscape

Global Platelet Rich Plasma Market is moderately competitive. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. Major Players include Johnson & Johnson, Arthrex, Inc., EmCyte Corporation and DR. PRP AMERICA, LLC. among others. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D.

Platelet Rich Plasma Market Top Player's Company Profiles

Arthrex Inc.
Cesca Therapeutics Inc.
DePuy Synthes Inc. (Johnson & Johnson)
Emcyte Corporation
Exactech Inc.
Harvest Technologies Corporation
ISTO Biologics
Medira GmbH
Zimmer Biomet Holdings Inc.
Stryker Corporation
Terumo Corporation
Glofinn Oy
Rmedica Co. Ltd.
Nuo Therapeutics Inc.
Regen Lab SA
Biomet Inc.
Selphyl Inc.
AdiStem Ltd.
Arteriocyte Medical Systems Inc.
Eclipse Aesthetics LLC

Platelet Rich Plasma Market

FAQs

Platelet Rich Plasma Market size was valued at USD 546.6 million in 2019 and is poised to grow from USD 629.19 million in 2023 to USD 2232.54 million by 2031, growing at a CAGR of 11.15% in the forecast period (2024-2031).

Platelet Rich Plasma Market is moderately competitive. To maintain a competitive edge, the major industry participants are continually implementing various growth strategies. Innovations, mergers, and acquisitions, collaborations and partnerships are adopted by these players to thrive in the competitive market. Major Players include Johnson & Johnson, Arthrex, Inc., EmCyte Corporation and DR. PRP AMERICA, LLC. among others. In order to provide industries with the most effective and economical solutions, the major market players are also continually concentrating on R&D. 'Arthrex Inc.', 'Cesca Therapeutics Inc.', 'DePuy Synthes Inc. (Johnson & Johnson)', 'Emcyte Corporation', 'Exactech Inc.', 'Harvest Technologies Corporation', 'ISTO Biologics', 'Medira GmbH', 'Zimmer Biomet Holdings Inc.', 'Stryker Corporation', 'Terumo Corporation', 'Glofinn Oy', 'Rmedica Co. Ltd.', 'Nuo Therapeutics Inc.', 'Regen Lab SA', 'Biomet Inc.', 'Selphyl Inc.', 'AdiStem Ltd.', 'Arteriocyte Medical Systems Inc.', 'Eclipse Aesthetics LLC'

The use of platelet-rich plasma in the treatment of orthopaedic diseases, musculoskeletal ailments, and sports injuries has seen a surge in demand. It focuses on growth factors and can speed up healing considerably. PRP is a significant source of personalised products for each patient in the field of regenerative medicine, supporting the cascade of wound healing and tissue restoration. These factors positively affect the market growth.

Human dermal cells that control hair follicle development are successfully multiplied by platelet-rich plasma. PRP has led to an overall rise in hair density, which is driving demand in the market both as a stand-alone treatment and in combination with hair transplant procedures. Given that PRP is an autologous product, it is thought to be safe and devoid of infectious infections. No major post-treatment adverse effects have been reported, however mild side effects including bruising, erythema, and crusting are thought to be rather prevalent. Researchers have discovered proof that PRP can stimulate fresh hair growth. To determine if PRP is efficient, however, further study is required because to the drawbacks of these trials, including as their small sample numbers and the variations in technique and procedure across physicians. The best PRP candidates must be found, and standardised treatment methods must be developed by medical professionals and researchers.

North America dominated the Platelet Rich Plasma Market share in 2021. This may be ascribed to the existence of several production facilities eager to create innovative PRP-based treatment methods, the high procurement at end-users including hospitals and clinics, and the presence of significant market participants. The market presence was reinforced by the assistance and approvals given by regulatory bodies. Such actions are predicted to increase market availability of platelet-rich plasma and speed up growth. During the projected period, it is predicted that the U.S. would provide promising growth opportunities. In the nation, PRP-based therapies are extensively used, with an increase in orthopaedic and aesthetic operations. The prominence of major players in the U.S together with the developed healthcare system in the nation, will also continue to influence the demand prognosis for platelet-rich plasma over the evaluation period. Due to these developments, the industry is anticipated to have a 3/10th market share.

Feedback From Our Clients

"We have purchased recently a report from SkyQuest Technology, and we are happy to inform you that this report was so useful and practical for our team. Skyquest Team was very active and our queries were followed up completely.It was amazing. "

- Mr. Ali Zali, Commercial Director, ICIIC Iran.

Platelet Rich Plasma Market Competitive Landscape

Platelet Rich Plasma Market Report Snapshots

Want to customize this report?

FAQs

Request Free Customization

Feedback From Our Clients

$5,300

Platelet Rich Plasma Market Competitive Landscape

Platelet Rich Plasma Market Report Snapshots

Want to customize this report?

FAQs

What is the market size of Platelet Rich Plasma Market?

Who are the key vendors in the Platelet Rich Plasma Market?

What is the key driver of Platelet Rich Plasma Market?

What is the key market trend for Platelet Rich Plasma Market?

Which region accounted for the largest share in Platelet Rich Plasma Market?

Request Free Customization

Related Reports

Feedback From Our Clients

$5,300